Predictive Oncology Inc. Files 8-K for Material Agreement

Ticker: AGPU · Form: 8-K · Filed: Mar 20, 2025 · CIK: 1446159

Sentiment: neutral

Topics: material-agreement, 8-k, corporate-actions

TL;DR

Predictive Oncology (POAI) filed an 8-K for a new material agreement on 3/14/25.

AI Summary

Predictive Oncology Inc. filed an 8-K on March 20, 2025, reporting a material definitive agreement entered into on March 14, 2025. The filing also includes other events and financial statements/exhibits. The company was formerly known as Skyline Medical Inc. and Precision Therapeutics Inc.

Why It Matters

This 8-K filing indicates a significant new agreement for Predictive Oncology Inc., which could impact its business operations and financial future.

Risk Assessment

Risk Level: medium — Material definitive agreements can introduce new risks or opportunities, and the specifics of this agreement are not detailed in the provided text, requiring further investigation.

Key Players & Entities

FAQ

What is the nature of the material definitive agreement entered into by Predictive Oncology Inc. on March 14, 2025?

The provided text states that an 8-K was filed on March 20, 2025, reporting an 'Entry into a Material Definitive Agreement' on March 14, 2025, but does not specify the details of the agreement.

What were Predictive Oncology Inc.'s previous names?

Predictive Oncology Inc. was formerly known as Precision Therapeutics Inc. and Skyline Medical Inc.

When was this 8-K filing submitted to the SEC?

The 8-K filing was submitted on March 20, 2025.

What is the primary SIC code listed for Predictive Oncology Inc.?

The primary SIC code listed is 3842 for ORTHOPEDIC, PROSTHETIC & SURGICAL APPLIANCES & SUPPLIES.

In which state is Predictive Oncology Inc. incorporated?

Predictive Oncology Inc. is incorporated in Delaware.

Filing Details

This Form 8-K (Form 8-K) was filed with the SEC on March 20, 2025 regarding Predictive Oncology Inc. (AGPU).

View full filing on EDGAR

View Full Filing

View this 8-K filing on SEC EDGAR

View on Read The Filing